Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Pharmacol Sci ; 136(3): 97-106, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29544683

RESUMO

The apoptotic process of erythrocytes is known as eryptosis, and is characterized by phosphatidylserine (PS) expression on the outer membrane. PS-positive erythrocytes are increased in sepsis, and PS is believed to facilitate coagulation of erythrocytes and activate macrophages. However, the relationship between eryptosis and abnormal coagulation in sepsis is still not fully understood. Histidine-rich glycoprotein (HRG) inhibits immunothrombus formation by regulating neutrophils and vascular endothelial cells. In the present study, we subjected isolated erythrocytes to Zn2+ stimulation, which activated their aggregation and PS expression. We then determined the Zn2+ contents in septic lung and kidney tissues, and found that they were elevated, suggesting that eryptosis was enhanced in these tissues. Erythrocyte adhesion to endothelial cells was also significantly increased after Zn2+ stimulation, and this effect was inhibited by HRG. Finally, we examined HRG treatment in septic model mice, and found that HRG decreased hemolysis, possibly due to its ability to bind heme. Our study demonstrated a novel Zn2+-initiated aggregation/thrombus formation pathway. We also showed the regulatory role of HRG in this pathway, together with the ability of HRG to inhibit hemolysis under septic conditions. HRG supplementation might be a novel therapeutic strategy for inflammatory disorders, especially sepsis.


Assuntos
Agregação Eritrocítica/efeitos dos fármacos , Hemólise/efeitos dos fármacos , Proteínas/farmacologia , Proteínas/fisiologia , Sepse/sangue , Animais , Células Cultivadas , Modelos Animais de Doenças , Eriptose , Eritrócitos/metabolismo , Heme/metabolismo , Humanos , Camundongos , Fosfatidilserinas , Ligação Proteica , Proteínas/metabolismo , Proteínas/uso terapêutico , Sepse/tratamento farmacológico , Trombose/induzido quimicamente , Compostos de Zinco/efeitos adversos
2.
J Med Invest ; 57(3-4): 224-31, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20847521

RESUMO

Hyperbaric air (HBA) is used to improve healing of wounds including diabetic ulcer. The aim of this study was to clarify the effects of HBA exposure on lipid and glucose metabolism in db/db mice. HBA did not influence the weight of db/db mice. Serum levels of free fatty acid and triglyceride, but not glucose and insulin, were significantly decreased after 6 weeks of treatment with HBA. The mRNA expressions of CPT-1, PPARα and PGC-1α genes, which are related to lipid metabolism, were significantly up-regulated in the muscle and liver. Increases in TNFα and MCP1 mRNA, which impaired lipid metabolism, were also attenuated by HBA treatment. These results suggest that exposure of HBA could have beneficial effects on lipid metabolism in patients with type 2 diabetes mellitus.


Assuntos
Oxigenoterapia Hiperbárica , Hiperlipidemias/terapia , Animais , Sequência de Bases , Glicemia/metabolismo , Carnitina O-Palmitoiltransferase/genética , Quimiocina CCL2/genética , Primers do DNA/genética , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/terapia , Ácidos Graxos não Esterificados/sangue , Humanos , Hiperlipidemias/genética , Hiperlipidemias/metabolismo , Insulina/sangue , Metabolismo dos Lipídeos , Masculino , Camundongos , Camundongos Mutantes , PPAR alfa/genética , Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Transativadores/genética , Fatores de Transcrição , Triglicerídeos/sangue , Fator de Necrose Tumoral alfa/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA